ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 19 filers reported holding ACHILLES THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,286,425 | -3.7% | 1,413,809 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,336,332 | -1.3% | 1,413,809 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,353,722 | +6.4% | 1,413,809 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,272,428 | -73.3% | 1,413,809 | -32.9% | 0.00% | -78.9% |
| Q3 2022 | $4,763,000 | +6.4% | 2,107,595 | +18.6% | 0.02% | 0.0% |
| Q2 2022 | $4,477,000 | +1.5% | 1,776,744 | +18.4% | 0.02% | +5.6% |
| Q1 2022 | $4,410,000 | -12.0% | 1,500,000 | +50.0% | 0.02% | -10.0% |
| Q4 2021 | $5,010,000 | +28.6% | 1,000,000 | +100.0% | 0.02% | +17.6% |
| Q3 2021 | $3,895,000 | – | 500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 11,086,909 | $27,939,000 | 39.70% |
| RA Capital Management | 5,014,687 | $12,637,000 | 0.34% |
| Artal Group S.A. | 2,255,375 | $5,684,000 | 0.30% |
| Redmile Group, LLC | 1,608,089 | $4,052,000 | 0.16% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 242,978 | $612,000 | 0.15% |
| Orbimed Advisors | 1,584,845 | $3,994,000 | 0.07% |
| Baker Brothers Advisors | 2,591,366 | $6,530,000 | 0.04% |
| Point72 Asset Management, L.P. | 1,776,744 | $4,477,000 | 0.02% |
| Woodline Partners LP | 233,180 | $588,000 | 0.01% |
| AXA S.A. | 567,310 | $1,429,811 | 0.00% |